0 XP   0   0   0

ABBOTT INDIA LTD.
Buy, Hold or Sell?

Should you buy, hold or sell Abbott?

I guess you are interested in ABBOTT INDIA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Abbott

Let's start. I'm going to help you getting a better view of ABBOTT INDIA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ABBOTT INDIA LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ABBOTT INDIA LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ABBOTT INDIA LTD.. The closing price on 2023-02-07 was INR20,958 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ABBOTT INDIA LTD. Daily Candlestick Chart
ABBOTT INDIA LTD. Daily Candlestick Chart
Summary









1. Valuation of Abbott




Current price per share

INR20,957.80

2. Growth of Abbott




Is Abbott growing?

Current yearPrevious yearGrowGrow %
How rich?$341.1m$314.8m$26.3m7.7%

How much money is Abbott making?

Current yearPrevious yearGrowGrow %
Making money$96.6m$83.5m$13m13.5%
Net Profit Margin16.3%16.0%--

How much money comes from the company's main activities?

3. Financial Health of Abbott




Comparing to competitors in the Drug Manufacturers-General industry




  Industry Rankings (Drug Manufacturers-General)  


Richest
#55 / 79

Most Revenue
#42 / 79

Most Profit
#36 / 79


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of ABBOTT INDIA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Abbott earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • A Net Profit Margin of 16.3% means that ₹0.16 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ABBOTT INDIA LTD.:

  • The MRQ is 16.3%. The company is making a huge profit. +2
  • The TTM is 16.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.3%TTM16.3%0.0%
TTM16.3%YOY16.0%+0.2%
TTM16.3%5Y14.3%+2.0%
5Y14.3%10Y12.9%+1.3%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ16.3%12.5%+3.8%
TTM16.3%15.3%+1.0%
YOY16.0%12.9%+3.1%
5Y14.3%13.0%+1.3%
10Y12.9%14.8%-1.9%
1.1.2. Return on Assets

Shows how efficient Abbott is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • 18.9% Return on Assets means that Abbott generated ₹0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ABBOTT INDIA LTD.:

  • The MRQ is 18.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 18.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.9%TTM18.9%0.0%
TTM18.9%YOY18.0%+0.9%
TTM18.9%5Y17.1%+1.8%
5Y17.1%10Y16.4%+0.7%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ18.9%1.8%+17.1%
TTM18.9%2.3%+16.6%
YOY18.0%1.8%+16.2%
5Y17.1%2.0%+15.1%
10Y16.4%2.2%+14.2%
1.1.3. Return on Equity

Shows how efficient Abbott is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • 28.3% Return on Equity means Abbott generated ₹0.28 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ABBOTT INDIA LTD.:

  • The MRQ is 28.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 28.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ28.3%TTM28.3%0.0%
TTM28.3%YOY26.5%+1.8%
TTM28.3%5Y25.1%+3.3%
5Y25.1%10Y23.8%+1.3%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ28.3%4.4%+23.9%
TTM28.3%4.8%+23.5%
YOY26.5%4.7%+21.8%
5Y25.1%4.4%+20.7%
10Y23.8%4.6%+19.2%

1.2. Operating Efficiency of ABBOTT INDIA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Abbott is operating .

  • Measures how much profit Abbott makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ABBOTT INDIA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y9.8%-9.8%
5Y9.8%10Y8.9%+0.9%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-18.0%-18.0%
YOY-17.8%-17.8%
5Y9.8%18.1%-8.3%
10Y8.9%18.1%-9.2%
1.2.2. Operating Ratio

Measures how efficient Abbott is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are ₹1.33 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 1.332. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.332. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.332TTM1.3320.000
TTM1.332YOY1.353-0.020
TTM1.3325Y1.382-0.050
5Y1.38210Y1.279+0.103
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3321.085+0.247
TTM1.3321.067+0.265
YOY1.3530.961+0.392
5Y1.3820.964+0.418
10Y1.2790.871+0.408

1.3. Liquidity of ABBOTT INDIA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Abbott is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Current Ratio of 3.20 means the company has ₹3.20 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 3.202. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.202. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.202TTM3.2020.000
TTM3.202YOY3.413-0.211
TTM3.2025Y3.365-0.163
5Y3.36510Y3.374-0.009
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2021.443+1.759
TTM3.2021.398+1.804
YOY3.4131.420+1.993
5Y3.3651.392+1.973
10Y3.3741.381+1.993
1.3.2. Quick Ratio

Measures if Abbott is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • A Quick Ratio of 2.40 means the company can pay off ₹2.40 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 2.402. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.402. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.402TTM2.4020.000
TTM2.402YOY2.360+0.043
TTM2.4025Y3.652-1.250
5Y3.65210Y3.472+0.180
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4020.894+1.508
TTM2.4020.822+1.580
YOY2.3600.788+1.572
5Y3.6520.851+2.801
10Y3.4720.830+2.642

1.4. Solvency of ABBOTT INDIA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Abbott assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abbott to Drug Manufacturers-General industry mean.
  • A Debt to Asset Ratio of 0.33 means that Abbott assets are financed with 33.2% credit (debt) and the remaining percentage (100% - 33.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 0.332. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.332. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.332TTM0.3320.000
TTM0.332YOY0.322+0.010
TTM0.3325Y0.317+0.015
5Y0.31710Y0.311+0.007
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3320.487-0.155
TTM0.3320.503-0.171
YOY0.3220.540-0.218
5Y0.3170.525-0.208
10Y0.3110.517-0.206
1.4.2. Debt to Equity Ratio

Measures if Abbott is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abbott to the Drug Manufacturers-General industry mean.
  • A Debt to Equity ratio of 49.8% means that company has ₹0.50 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 0.498. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.498. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.498TTM0.4980.000
TTM0.498YOY0.476+0.022
TTM0.4985Y0.465+0.033
5Y0.46510Y0.452+0.013
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4980.952-0.454
TTM0.4981.033-0.535
YOY0.4761.157-0.681
5Y0.4651.140-0.675
10Y0.4521.085-0.633

2. Market Valuation of ABBOTT INDIA LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Abbott generates.

  • Above 15 is considered overpriced but always compare Abbott to the Drug Manufacturers-General industry mean.
  • A PE ratio of 47.09 means the investor is paying ₹47.09 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ABBOTT INDIA LTD.:

  • The EOD is 55.758. Good. +1
  • The MRQ is 47.089. Good. +1
  • The TTM is 47.089. Good. +1
Trends
Current periodCompared to+/- 
EOD55.758MRQ47.089+8.669
MRQ47.089TTM47.0890.000
TTM47.089YOY46.113+0.976
TTM47.0895Y42.376+4.713
5Y42.37610Y40.957+1.419
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD55.75874.978-19.220
MRQ47.08984.344-37.255
TTM47.08977.005-29.916
YOY46.11385.751-39.638
5Y42.37677.578-35.202
10Y40.95767.220-26.263
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Abbott.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ABBOTT INDIA LTD.:

  • The MRQ is 40.721. Seems overpriced? -1
  • The TTM is 40.721. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ40.721TTM40.7210.000
TTM40.721YOY39.586+1.135
TTM40.7215Y34.590+6.131
5Y34.59010Y34.304+0.286
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ40.721-0.722+41.443
TTM40.721-0.006+40.727
YOY39.586-+39.586
5Y34.590-0.292+34.882
10Y34.304-0.062+34.366

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Abbott is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A PB ratio of 13.34 means the investor is paying ₹13.34 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ABBOTT INDIA LTD.:

  • The EOD is 15.793. Seems overpriced? -1
  • The MRQ is 13.338. Seems overpriced? -1
  • The TTM is 13.338. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD15.793MRQ13.338+2.455
MRQ13.338TTM13.3380.000
TTM13.338YOY12.240+1.098
TTM13.3385Y10.729+2.609
5Y10.72910Y9.874+0.855
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD15.7932.964+12.829
MRQ13.3383.222+10.116
TTM13.3383.620+9.718
YOY12.2403.578+8.662
5Y10.7293.172+7.557
10Y9.8743.020+6.854
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ABBOTT INDIA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--102.417102.4170%80.214+28%134.861-24%189.572-46%
Book Value Growth--1.0841.0840%1.070+1%1.154-6%1.155-6%
Book Value Per Share--1327.0041327.0040%1224.586+8%1087.566+22%950.455+40%
Book Value Per Share Growth--1.0841.0840%1.070+1%1.154-6%1.155-6%
Current Ratio--3.2023.2020%3.413-6%3.365-5%3.374-5%
Debt To Asset Ratio--0.3320.3320%0.322+3%0.317+5%0.311+7%
Debt To Equity Ratio--0.4980.4980%0.476+5%0.465+7%0.452+10%
Dividend Per Share--275.002275.0020%249.999+10%133.000+107%104.429+163%
Dividend Per Share Growth--1.1001.1000%5.000-78%1.899-42%1.770-38%
Eps--375.871375.8710%325.041+16%276.138+36%233.001+61%
Eps Growth--1.1561.1560%1.165-1%1.242-7%1.216-5%
Free Cash Flow Per Share--425.233425.2330%331.037+28%266.595+60%224.881+89%
Free Cash Flow Per Share Growth--1.2851.2850%1.152+11%1.586-19%1.533-16%
Free Cash Flow To Equity Per Share--425.233425.2330%331.037+28%223.110+91%182.388+133%
Free Cash Flow To Equity Per Share Growth--1.2851.2850%1.787-28%3.513-63%3.153-59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9093.133--------
Intrinsic Value_10Y_min--7635.417--------
Intrinsic Value_1Y_max--531.196--------
Intrinsic Value_1Y_min--516.162--------
Intrinsic Value_3Y_max--1885.632--------
Intrinsic Value_3Y_min--1775.675--------
Intrinsic Value_5Y_max--3589.231--------
Intrinsic Value_5Y_min--3271.927--------
Net Profit Margin--0.1630.1630%0.160+1%0.143+14%0.129+26%
Operating Margin----0%-0%0.098-100%0.089-100%
Operating Ratio--1.3321.3320%1.353-2%1.382-4%1.279+4%
Pb Ratio15.793+16%13.33813.3380%12.240+9%10.729+24%9.874+35%
Pe Ratio55.758+16%47.08947.0890%46.113+2%42.376+11%40.957+15%
Peg Ratio--40.72140.7210%39.586+3%34.590+18%34.304+19%
Price Per Share20957.801+16%17699.45017699.4500%14988.650+18%12177.910+45%10033.700+76%
Price To Total Gains Ratio55.529+16%46.89646.8960%45.391+3%44.138+6%37.960+24%
Profit Growth--1.1561.1560%1.165-1%1.242-7%1.216-5%
Quick Ratio--2.4022.4020%2.360+2%3.652-34%3.472-31%
Return On Assets--0.1890.1890%0.180+5%0.171+11%0.164+15%
Return On Equity--0.2830.2830%0.265+7%0.251+13%0.238+19%
Revenue Growth--1.1401.1400%1.053+8%1.113+2%1.109+3%
Total Gains Per Share--377.419377.4190%330.213+14%267.861+41%294.001+28%
Total Gains Per Share Growth--1.1431.1430%1.325-14%1.255-9%1.081+6%
Usd Book Value--341194590.000341194590.0000%314861360.000+8%279631137.940+22%244377627.529+40%
Usd Book Value Change Per Share--1.2391.2390%0.971+28%1.632-24%2.294-46%
Usd Book Value Per Share--16.05716.0570%14.817+8%13.160+22%11.501+40%
Usd Dividend Per Share--3.3283.3280%3.025+10%1.609+107%1.264+163%
Usd Eps--4.5484.5480%3.933+16%3.341+36%2.819+61%
Usd Free Cash Flow--109334390.000109334390.0000%85115030.000+28%68546032.940+60%48961452.100+123%
Usd Free Cash Flow Per Share--5.1455.1450%4.006+28%3.226+60%2.721+89%
Usd Free Cash Flow To Equity Per Share--5.1455.1450%4.006+28%2.700+91%2.207+133%
Usd Price Per Share253.589+16%214.163214.1630%181.363+18%147.353+45%121.408+76%
Usd Profit--96642700.00096642700.0000%83573490.000+16%70999644.320+36%59908282.343+61%
Usd Revenue--594146300.000594146300.0000%521284940.000+14%490413745.360+21%445887952.400+33%
Usd Total Gains Per Share--4.5674.5670%3.996+14%3.241+41%3.557+28%
 EOD+2 -3MRQTTM+0 -0YOY+29 -125Y+23 -1910Y+23 -19

3.2. Fundamental Score

Let's check the fundamental score of ABBOTT INDIA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1555.758
Price to Book Ratio (EOD)Between0-115.793
Net Profit Margin (MRQ)Greater than00.163
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.402
Current Ratio (MRQ)Greater than13.202
Debt to Asset Ratio (MRQ)Less than10.332
Debt to Equity Ratio (MRQ)Less than10.498
Return on Equity (MRQ)Greater than0.150.283
Return on Assets (MRQ)Greater than0.050.189
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of ABBOTT INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.232
Ma 20Greater thanMa 5021,483.192
Ma 50Greater thanMa 10021,239.841
Ma 100Greater thanMa 20020,056.016
OpenGreater thanClose20,894.551
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets42,241,200
Total Liabilities14,043,300
Total Stockholder Equity28,197,900
 As reported
Total Liabilities 14,043,300
Total Stockholder Equity+ 28,197,900
Total Assets = 42,241,200

Assets

Total Assets42,241,200
Total Current Assets38,530,400
Long-term Assets38,530,400
Total Current Assets
Cash And Cash Equivalents 1,327,100
Short-term Investments 26,024,700
Net Receivables 2,881,600
Inventory 6,878,200
Other Current Assets 555,900
Total Current Assets  (as reported)38,530,400
Total Current Assets  (calculated)37,667,500
+/- 862,900
Long-term Assets
Intangible Assets 86,300
Long-term Assets Other 39,300
Long-term Assets  (as reported)3,710,800
Long-term Assets  (calculated)125,600
+/- 3,585,200

Liabilities & Shareholders' Equity

Total Current Liabilities12,031,900
Long-term Liabilities2,011,400
Total Stockholder Equity28,197,900
Total Current Liabilities
Accounts payable 8,894,500
Other Current Liabilities 493,600
Total Current Liabilities  (as reported)12,031,900
Total Current Liabilities  (calculated)9,388,100
+/- 2,643,800
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,516,900
Long-term Liabilities  (as reported)2,011,400
Long-term Liabilities  (calculated)1,516,900
+/- 494,500
Total Stockholder Equity
Retained Earnings 21,584,000
Total Stockholder Equity (as reported)28,197,900
Total Stockholder Equity (calculated)21,584,000
+/- 6,613,900
Other
Capital Stock212,500
Common Stock Shares Outstanding 21,249
Net Invested Capital 28,197,900
Net Working Capital 26,498,500



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
> Total Assets 
16,165,079
20,638,082
24,161,891
29,409,116
35,468,500
38,404,500
42,241,200
42,241,20038,404,50035,468,50029,409,11624,161,89120,638,08216,165,079
   > Total Current Assets 
14,506,320
18,930,168
22,654,720
27,609,845
32,046,399
35,185,200
38,530,400
38,530,40035,185,20032,046,39927,609,84522,654,72018,930,16814,506,320
       Cash And Cash Equivalents 
1,401,908
2,022,358
376,771
1,370,061
21,973,800
2,182,700
1,327,100
1,327,1002,182,70021,973,8001,370,061376,7712,022,3581,401,908
       Short-term Investments 
0
8,826,000
9,873,500
15,420,760
20,733,615
21,821,600
26,024,700
26,024,70021,821,60020,733,61515,420,7609,873,5008,826,0000
       Net Receivables 
1,450,202
2,300,840
5,639,854
4,292,079
4,539,008
2,502,100
2,881,600
2,881,6002,502,1004,539,0084,292,0795,639,8542,300,8401,450,202
       Inventory 
3,701,029
5,006,312
5,853,272
6,067,883
5,271,651
7,175,900
6,878,200
6,878,2007,175,9005,271,6516,067,8835,853,2725,006,3123,701,029
       Other Current Assets 
207,122
721,254
856,910
396,835
261,243
528,600
555,900
555,900528,600261,243396,835856,910721,254207,122
   > Long-term Assets 
0
1,732,564
1,507,171
1,799,271
3,422,087
3,219,300
3,710,800
3,710,8003,219,3003,422,0871,799,2711,507,1711,732,5640
       Property Plant Equipment 
1,078,027
1,127,952
807,525
1,038,403
2,705,709
0
0
002,705,7091,038,403807,5251,127,9521,078,027
       Intangible Assets 
34,881
30,814
27,960
18,508
9,000
11,700
86,300
86,30011,7009,00018,50827,96030,81434,881
       Long-term Assets Other 
0
0
0
0
0
60,600
39,300
39,30060,60000000
> Total Liabilities 
4,209,089
6,768,642
7,234,286
9,323,264
11,151,400
12,382,900
14,043,300
14,043,30012,382,90011,151,4009,323,2647,234,2866,768,6424,209,089
   > Total Current Liabilities 
3,822,735
6,316,408
6,680,835
8,568,934
8,911,006
10,308,600
12,031,900
12,031,90010,308,6008,911,0068,568,9346,680,8356,316,4083,822,735
       Accounts payable 
0
4,746,934
4,806,248
6,635,157
6,577,718
7,626,700
8,894,500
8,894,5007,626,7006,577,7186,635,1574,806,2484,746,9340
       Other Current Liabilities 
0
666,365
938,845
929,566
969,041
372,400
493,600
493,600372,400969,041929,566938,845666,3650
   > Long-term Liabilities 
0
472,195
553,451
754,330
2,240,407
2,074,300
2,011,400
2,011,4002,074,3002,240,407754,330553,451472,1950
       Long term Debt Total 
0
0
0
0
1,392,000
0
0
001,392,0000000
       Other Liabilities 
0
472,195
553,451
754,330
848,375
0
0
00848,375754,330553,451472,1950
> Total Stockholder Equity
11,955,990
13,869,440
16,927,595
20,085,852
24,317,100
26,021,600
28,197,900
28,197,90026,021,60024,317,10020,085,85216,927,59513,869,44011,955,990
   Common Stock
212,493
212,493
212,493
212,493
212,493
0
0
00212,493212,493212,493212,493212,493
   Retained Earnings 
11,659,677
13,471,183
16,463,834
19,575,021
23,775,685
20,239,300
21,584,000
21,584,00020,239,30023,775,68519,575,02116,463,83413,471,18311,659,677
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
0
185,764
251,278
298,338
328,895
0
0
00328,895298,338251,278185,7640



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue49,103,000
Cost of Revenue-26,572,100
Gross Profit22,530,90022,530,900
 
Operating Income (+$)
Gross Profit22,530,900
Operating Expense-38,838,500
Operating Income10,264,500-16,307,600
 
Operating Expense (+$)
Research Development-
Selling General Administrative4,081,700
Selling And Marketing Expenses-
Operating Expense38,838,5004,081,700
 
Net Interest Income (+$)
Interest Income760,600
Interest Expense-191,000
Net Interest Income569,600569,600
 
Pretax Income (+$)
Operating Income10,264,500
Net Interest Income569,600
Other Non-Operating Income Expenses-
Income Before Tax (EBT)10,797,30010,264,500
EBIT - interestExpense = -191,000
7,987,000
8,178,000
Interest Expense191,000
Earnings Before Interest and Taxes (ebit)-10,988,300
Earnings Before Interest and Taxes (ebitda)11,649,300
 
After tax Income (+$)
Income Before Tax10,797,300
Tax Provision-2,810,300
Net Income From Continuing Ops7,987,0007,987,000
Net Income7,987,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--569,600
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NIACL.BSE
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.BSE.

NIACL.BSE Daily Candlestick Chart
NIACL.NSE
6 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NIACL.NSE.

NIACL.NSE Daily Candlestick Chart
NGIL.BSE
6 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of NGIL.BSE.

NGIL.BSE Daily Candlestick Chart
VAVA.XETRA
15 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VAVA.XETRA.

VAVA.XETRA Daily Candlestick Chart
O39.SG
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of O39.SG.

O39.SG Daily Candlestick Chart
M44U.SG
24 minutes ago

I found you a Golden Cross on the daily chart of M44U.SG.

M44U.SG Daily Candlestick Chart
F9D.SG
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of F9D.SG.

F9D.SG Daily Candlestick Chart
A7RU.SG
29 minutes ago

I found you a Golden Cross on the daily chart of A7RU.SG.

A7RU.SG Daily Candlestick Chart
CHJ.SG
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHJ.SG.

CHJ.SG Daily Candlestick Chart
PSE.VN
35 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PSE.VN.

PSE.VN Daily Candlestick Chart
QTXB.PINK
53 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of QTXB.PINK.

QTXB.PINK Daily Candlestick Chart
33637L.KO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 33637L.KO.

33637L.KO Daily Candlestick Chart
LOOMIS.ST
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LOOMIS.ST.

LOOMIS.ST Daily Candlestick Chart
KFAST-B.ST
1 hour ago

I found you a Golden Cross on the daily chart of KFAST-B.ST.

KFAST-B.ST Daily Candlestick Chart
COALA.ST
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of COALA.ST.

COALA.ST Daily Candlestick Chart
CFISH.ST
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CFISH.ST.

CFISH.ST Daily Candlestick Chart
UIFS.LSE
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UIFS.LSE.

UIFS.LSE Daily Candlestick Chart
RNF.F
1 hour ago

I found you a RSI Bullish Hidden Divergence on the daily chart of RNF.F.

RNF.F Daily Candlestick Chart
IXX.F
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IXX.F.

IXX.F Daily Candlestick Chart
4AP.F
1 hour ago

I found you a MACD Bearish Hidden Divergence on the daily chart of 4AP.F.

4AP.F Daily Candlestick Chart
5IC.SG
4 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 5IC.SG.

5IC.SG Daily Candlestick Chart
INFOMEDIA.BSE
4 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of INFOMEDIA.BSE.

INFOMEDIA.BSE Daily Candlestick Chart
PNAX.TA
4 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PNAX.TA.

PNAX.TA Daily Candlestick Chart
SHI.VN
4 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHI.VN.

SHI.VN Daily Candlestick Chart
HLC.VN
4 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HLC.VN.

HLC.VN Daily Candlestick Chart